Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 13, 2024BMC Infectious DiseasesOpen Access

Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

View Full Paper
Ask AI
Bookmark
Share

Authors

OAOhoud AljuhaniGKGhazwa B. KorayemAAAli F. Altebainawi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aljuhani et al. (2024) studied this question.

synapsesocial.com/papers/68e79585b6db643587706386https://doi.org/10.1186/s12879-024-09056-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia.1987 · 255 citations
  2. 2Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia2000 · 144 citations
  3. 3Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial2020 · 472 citations
  4. 4Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-192020 · 894 citations
  5. 5Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial2021 · 253 citations